BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 21518409)

  • 41. Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique.
    Hager J; Blanché H; Sun F; Vaxillaire NV; Poller W; Cohen D; Czernichow P; Velho G; Robert JJ; Cohen N
    Diabetes; 1994 May; 43(5):730-3. PubMed ID: 8168652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
    Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
    PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel synonymous substitution in the GCK gene causes aberrant splicing in an Italian patient with GCK-MODY phenotype.
    Costantini S; Prandini P; Corradi M; Pasquali A; Contreas G; Pignatti PF; Pinelli L; Trabetti E; Maffeis C
    Diabetes Res Clin Pract; 2011 Apr; 92(1):e23-6. PubMed ID: 21288587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
    Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
    Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
    Rica I; Luzuriaga C; Pérez de Nanclares G; Estalella I; Aragonés A; Barrio R; Bilbao JR; Carlés C; Fernández C; Fernández JM; Fernández-Rebollo E; Gastaldo E; Giralt P; Gomez Vida JM; Gutiérrez A; López Siguero JP; Martínez-Aedo MJ; Muñoz M; Prieto J; Rodrigo J; Vargas F; Castano L
    Diabet Med; 2007 Jul; 24(7):707-13. PubMed ID: 17490422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular diagnosis on indication of maturity onset diabetes of the young; results from 184 patients].
    Losekoot M; Broekman AJ; Breuning MH; de Koning EJ; Romijn JA; Maassen JA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):139-43. PubMed ID: 15693590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).
    Cuesta-Muñoz AL; Tuomi T; Cobo-Vuilleumier N; Koskela H; Odili S; Stride A; Buettger C; Otonkoski T; Froguel P; Grimsby J; Garcia-Gimeno M; Matschinsky FM
    Diabetes Care; 2010 Feb; 33(2):290-2. PubMed ID: 19903754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
    Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
    Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization.
    Owen K; Hattersley AT
    Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability.
    Raimondo A; Chakera AJ; Thomsen SK; Colclough K; Barrett A; De Franco E; Chatelas A; Demirbilek H; Akcay T; Alawneh H; ; Flanagan SE; Van De Bunt M; Hattersley AT; Gloyn AL; Ellard S;
    Hum Mol Genet; 2014 Dec; 23(24):6432-40. PubMed ID: 25015100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and bioinformatics analysis of four novel GCK missense variants detected in Caucasian families with GCK-MODY phenotype.
    Costantini S; Malerba G; Contreas G; Corradi M; Marin Vargas SP; Giorgetti A; Maffeis C
    Clin Genet; 2015 May; 87(5):440-7. PubMed ID: 24735133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young.
    Sun F; Knebelmann B; Pueyo ME; Zouali H; Lesage S; Vaxillaire M; Passa P; Cohen D; Velho G; Antignac C
    J Clin Invest; 1993 Sep; 92(3):1174-80. PubMed ID: 8376578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population.
    Borowiec M; Antosik K; Fendler W; Deja G; Jarosz-Chobot P; Mysliwiec M; Zmyslowska A; Malecki M; Szadkowska A; Mlynarski W
    Clin Genet; 2012 Mar; 81(3):278-83. PubMed ID: 21348868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.
    Kristinsson SY; Thorolfsdottir ET; Talseth B; Steingrimsson E; Thorsson AV; Helgason T; Hreidarsson AB; Arngrimsson R
    Diabetologia; 2001 Nov; 44(11):2098-103. PubMed ID: 11719843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of a homozygous GCK missense mutation with mild diabetes.
    Marucci A; Biagini T; Di Paola R; Menzaghi C; Fini G; Castellana S; Cardinale GM; Mazza T; Trischitta V
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00728. PubMed ID: 31197960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel glucokinase deletion (p.Lys32del) and five previously described mutations co-segregate with the phenotype of mild familial hyperglycaemia (MODY2) in Brazilian families.
    Giuffrida FM; Calliari LE; Manna TD; Ferreira JG; Saddi-Rosa P; Kunii IS; Furuzawa GK; Dias-da-Silva MR; Reis AF
    Diabetes Res Clin Pract; 2013 May; 100(2):e42-5. PubMed ID: 23433541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.